Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-31DOI: 10.1007/s12028-024-02080-5
Teodor Svedung Wettervik, Anders Hånell, Kerstin M Ahlgren, Lars Hillered, Anders Lewén
{"title":"Preliminary Observations of the Loke Microdialysis in an Experimental Pig Model: Are We Ready for Continuous Monitoring of Brain Energy Metabolism?","authors":"Teodor Svedung Wettervik, Anders Hånell, Kerstin M Ahlgren, Lars Hillered, Anders Lewén","doi":"10.1007/s12028-024-02080-5","DOIUrl":"10.1007/s12028-024-02080-5","url":null,"abstract":"<p><strong>Background: </strong>Brain energy metabolism is often disturbed after acute brain injuries. Current neuromonitoring methods with cerebral microdialysis (CMD) are based on intermittent measurements (1-4 times/h), but such a low frequency could miss transient but important events. The solution may be the recently developed Loke microdialysis (MD), which provides high-frequency data of glucose and lactate. Before clinical implementation, the reliability and stability of Loke remain to be determined in vivo. The purpose of this study was to validate Loke MD in relation to the standard intermittent CMD method.</p><p><strong>Methods: </strong>Four pigs aged 2-3 months were included. They received two adjacent CMD catheters, one for standard intermittent assessments and one for continuous (Loke MD) assessments of glucose and lactate. The standard CMD was measured every 15 min. Continuous Loke MD was sampled every 2-3 s and was averaged over corresponding 15-min intervals for the statistical comparisons with standard CMD. Intravenous glucose injections and intracranial hypertension by inflation of an intracranial epidural balloon were performed to induce variations in intracranial pressure, cerebral perfusion pressure, and systemic and cerebral glucose and lactate levels.</p><p><strong>Results: </strong>In a linear mixed-effect model of standard CMD glucose (mM), there was a fixed effect value (± standard error [SE]) at 0.94 ± 0.07 (p < 0.001) for Loke MD glucose (mM), with an intercept at - 0.19 ± 0.15 (p = 0.20). The model showed a conditional R<sup>2</sup> at 0.81 and a marginal R<sup>2</sup> at 0.72. In a linear mixed-effect model of standard CMD lactate (mM), there was a fixed effect value (± SE) at 0.41 ± 0.16 (p = 0.01) for Loke MD lactate (mM), with an intercept at 0.33 ± 0.21 (p = 0.25). The model showed a conditional R<sup>2</sup> at 0.47 and marginal R<sup>2</sup> at 0.17.</p><p><strong>Conclusions: </strong>The established standard CMD glucose thresholds may be used as for Loke MD with some caution, but this should be avoided for lactate.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"222-231"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811243/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141860426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-02DOI: 10.1007/s12028-024-02036-9
Charlene J Ong, Qiuxi Huang, Ivy So Yeon Kim, Jack Pohlmann, Stefanos Chatzidakis, Benjamin Brush, Yihan Zhang, Yili Du, Leigh Ann Malinger, Emelia J Benjamin, Josée Dupuis, David M Greer, Stelios M Smirnakis, Ludovic Trinquart
{"title":"Association of Dynamic Trajectories of Time-Series Data and Life-Threatening Mass Effect in Large Middle Cerebral Artery Stroke.","authors":"Charlene J Ong, Qiuxi Huang, Ivy So Yeon Kim, Jack Pohlmann, Stefanos Chatzidakis, Benjamin Brush, Yihan Zhang, Yili Du, Leigh Ann Malinger, Emelia J Benjamin, Josée Dupuis, David M Greer, Stelios M Smirnakis, Ludovic Trinquart","doi":"10.1007/s12028-024-02036-9","DOIUrl":"10.1007/s12028-024-02036-9","url":null,"abstract":"<p><strong>Background: </strong>Life-threatening, space-occupying mass effect due to cerebral edema and/or hemorrhagic transformation is an early complication of patients with middle cerebral artery stroke. Little is known about longitudinal trajectories of laboratory and vital signs leading up to radiographic and clinical deterioration related to this mass effect.</p><p><strong>Methods: </strong>We curated a retrospective data set of 635 patients with large middle cerebral artery stroke totaling 95,463 data points for 10 longitudinal covariates and 40 time-independent covariates. We assessed trajectories of the 10 longitudinal variables during the 72 h preceding three outcomes representative of life-threatening mass effect: midline shift ≥ 5 mm, pineal gland shift (PGS) > 4 mm, and decompressive hemicraniectomy (DHC). We used a \"backward-looking\" trajectory approach. Patients were aligned based on outcome occurrence time and the trajectory of each variable was assessed before that outcome by accounting for cases and noncases, adjusting for confounders. We evaluated longitudinal trajectories with Cox proportional time-dependent regression.</p><p><strong>Results: </strong>Of 635 patients, 49.0% were female, and the mean age was 69 years. Thirty five percent of patients had midline shift ≥ 5 mm, 24.3% of patients had PGS > 4 mm, and 10.7% of patients underwent DHC. Backward-looking trajectories showed mild increases in white blood cell count (10-11 K/UL within 72 h), temperature (up to half a degree within 24 h), and sodium levels (1-3 mEq/L within 24 h) before the three outcomes of interest. We also observed a decrease in heart rate (75-65 beats per minute) 24 h before DHC. We found a significant association between increased white blood cell count with PGS > 4 mm (hazard ratio 1.05, p value 0.007).</p><p><strong>Conclusions: </strong>Longitudinal profiling adjusted for confounders demonstrated that white blood cell count, temperature, and sodium levels appear to increase before radiographic and clinical indicators of space-occupying mass effect. These findings will inform the development of multivariable dynamic risk models to aid prediction of life-threatening, space-occupying mass effect.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"77-89"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11693775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-02DOI: 10.1007/s12028-024-02051-w
Laura Sieh, Emma Peasley, Eric Mao, Amanda Mitchell, Gregory Heinonen, Shivani Ghoshal, Sachin Agarwal, Soojin Park, E Sander Connolly, Jan Claassen, Ernest E Moore, Kirk Hansen, Eldad A Hod, Richard O Francis, David J Roh
{"title":"Admission Viscoelastic Hemostatic Assay Parameters Predict Poor Long-Term Intracerebral Hemorrhage Outcomes.","authors":"Laura Sieh, Emma Peasley, Eric Mao, Amanda Mitchell, Gregory Heinonen, Shivani Ghoshal, Sachin Agarwal, Soojin Park, E Sander Connolly, Jan Claassen, Ernest E Moore, Kirk Hansen, Eldad A Hod, Richard O Francis, David J Roh","doi":"10.1007/s12028-024-02051-w","DOIUrl":"10.1007/s12028-024-02051-w","url":null,"abstract":"<p><strong>Background: </strong>Viscoelastic hemostatic assays (VHAs) provide more comprehensive assessments of coagulation compared with conventional coagulation assays. Although VHAs have enabled guided hemorrhage control therapies, improving clinical outcomes in life-threatening hemorrhage, the role of VHAs in intracerebral hemorrhage (ICH) is unclear. If VHAs can identify coagulation abnormalities relevant for ICH outcomes, this would support the need to investigate the role of VHAs in ICH treatment paradigms. Thus, we investigated whether VHA assessments of coagulation relate to long-term ICH outcomes.</p><p><strong>Methods: </strong>Patients with spontaneous ICH enrolled into a single-center cohort study receiving admission Rotational Thromboelastometry (ROTEM) VHA testing between 2013 and 2020 were assessed. Patients with previous anticoagulant use or coagulopathy on conventional coagulation assays were excluded. Primary ROTEM exposure variables were coagulation kinetics and clot strength assessments. Poor long-term outcome was defined as modified Rankin Scale ≥ 4 at 6 months. Logistic regression analyses assessed associations of ROTEM parameters with clinical outcomes after adjusting for ICH severity and hemoglobin concentration.</p><p><strong>Results: </strong>Of 44 patients analyzed, the mean age was 64 years, 57% were female, and the median ICH volume was 23 mL. Poor 6-month outcome was seen in 64% of patients. In our multivariable regression models, slower, prolonged coagulation kinetics (adjusted odds ratio for every second increase in clot formation time 1.04, 95% confidence interval 1.00-1.09, p = 0.04) and weaker clot strength (adjusted odds ratio for every millimeter increase of maximum clot firmness 0.84, 95% confidence interval 0.71-0.99, p = 0.03) were separately associated with poor long-term outcomes.</p><p><strong>Conclusions: </strong>Slower, prolonged coagulation kinetics and weaker clot strength on admission VHA ROTEM testing, not attributable to anticoagulant use, were associated with poor long-term outcomes after ICH. Further work is needed to clarify the generalizability and the underlying mechanisms of these VHA findings to assess whether VHA-guided treatments should be incorporated into ICH care.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"100-107"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141492803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Megan E Barra, Elizabeth K Zink, Thomas P Bleck, Eder Cáceres, Salia Farrokh, Brandon Foreman, Emilio Garzón Cediel, J Claude Hemphill, Masao Nagayama, DaiWai M Olson, Jose I Suarez
{"title":"Correction: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Hospital Course, Confounders, and Medications.","authors":"Megan E Barra, Elizabeth K Zink, Thomas P Bleck, Eder Cáceres, Salia Farrokh, Brandon Foreman, Emilio Garzón Cediel, J Claude Hemphill, Masao Nagayama, DaiWai M Olson, Jose I Suarez","doi":"10.1007/s12028-024-02099-8","DOIUrl":"10.1007/s12028-024-02099-8","url":null,"abstract":"","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"321-322"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142018153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-08-23DOI: 10.1007/s12028-024-02103-1
Kertee Goswami, Lata Kumari, Muhammad Maaz
{"title":"Letter to the Editor: Acute Skeletal Muscle Wasting is Associated with Prolonged Hospital Stay in Critical Illness with Brain Injury.","authors":"Kertee Goswami, Lata Kumari, Muhammad Maaz","doi":"10.1007/s12028-024-02103-1","DOIUrl":"10.1007/s12028-024-02103-1","url":null,"abstract":"","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"301-302"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142046873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-07-09DOI: 10.1007/s12028-024-02050-x
Felix Klawitter, Friederike Laukien, Dagmar-C Fischer, Anja Rahn, Katrin Porath, Lena Danckert, Rika Bajorat, Uwe Walter, Robert Patejdl, Johannes Ehler
{"title":"Longitudinal Assessment of Blood-Based Inflammatory, Neuromuscular, and Neurovascular Biomarker Profiles in Intensive Care Unit-Acquired Weakness: A Prospective Single-Center Cohort Study.","authors":"Felix Klawitter, Friederike Laukien, Dagmar-C Fischer, Anja Rahn, Katrin Porath, Lena Danckert, Rika Bajorat, Uwe Walter, Robert Patejdl, Johannes Ehler","doi":"10.1007/s12028-024-02050-x","DOIUrl":"10.1007/s12028-024-02050-x","url":null,"abstract":"<p><strong>Background: </strong>The diagnosis of intensive care unit (ICU)-acquired weakness (ICUAW) and critical illness neuromyopathy (CINM) is frequently hampered in the clinical routine. We evaluated a novel panel of blood-based inflammatory, neuromuscular, and neurovascular biomarkers as an alternative diagnostic approach for ICUAW and CINM.</p><p><strong>Methods: </strong>Patients admitted to the ICU with a Sequential Organ Failure Assessment score of ≥ 8 on 3 consecutive days within the first 5 days as well as healthy controls were enrolled. The Medical Research Council Sum Score (MRCSS) was calculated, and motor and sensory electroneurography (ENG) for assessment of peripheral nerve function were performed at days 3 and 10. ICUAW was defined by an MRCSS < 48 and CINM by pathological ENG alterations, both at day 10. Blood samples were taken at days 3, 10, and 17 for quantitative analysis of 18 different biomarkers (white blood cell count, C-reactive protein, procalcitonin, C-terminal agrin filament, fatty-acid-binding protein 3, growth and differentiation factor 15, syndecan 1, troponin I, interferon-γ, tumor necrosis factor-α, interleukin-1α [IL-1α], IL-1β, IL-4, IL-6, IL-8, IL-10, IL-13, and monocyte chemoattractant protein 1). Results of the biomarker analysis were categorized according to the ICUAW and CINM status. Clinical outcome was assessed after 3 months.</p><p><strong>Results: </strong>Between October 2016 and December 2018, 38 critically ill patients, grouped into ICUAW (18 with and 20 without) and CINM (18 with and 17 without), as well as ten healthy volunteers were included. Biomarkers were significantly elevated in critically ill patients compared to healthy controls and correlated with disease severity and 3-month outcome parameters. However, none of the biomarkers enabled discrimination of patients with and without neuromuscular impairment, irrespective of applied classification.</p><p><strong>Conclusions: </strong>Blood-based biomarkers are generally elevated in ICU patients but do not identify patients with ICUAW or CINM.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov identifier: NCT02706314.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"118-130"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11811256/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-08-06DOI: 10.1007/s12028-024-02067-2
Julianne Murphy, Juliana Silva Pinheiro do Nascimento, Ethan J Houskamp, Hanyin Wang, Meghan Hutch, Yuzhe Liu, Roland Faigle, Andrew M Naidech
{"title":"Phenotypes of Patients with Intracerebral Hemorrhage, Complications, and Outcomes.","authors":"Julianne Murphy, Juliana Silva Pinheiro do Nascimento, Ethan J Houskamp, Hanyin Wang, Meghan Hutch, Yuzhe Liu, Roland Faigle, Andrew M Naidech","doi":"10.1007/s12028-024-02067-2","DOIUrl":"10.1007/s12028-024-02067-2","url":null,"abstract":"<p><strong>Background: </strong>The objective of this study was to define clinically meaningful phenotypes of intracerebral hemorrhage (ICH) using machine learning.</p><p><strong>Methods: </strong>We used patient data from two US medical centers and the Antihypertensive Treatment of Acute Cerebral Hemorrhage-II clinical trial. We used k-prototypes to partition patient admission data. We then used silhouette method calculations and elbow method heuristics to optimize the clusters. Associations between phenotypes, complications (e.g., seizures), and functional outcomes were assessed using the Kruskal-Wallis H-test or χ<sup>2</sup> test.</p><p><strong>Results: </strong>There were 916 patients; the mean age was 63.8 ± 14.1 years, and 426 patients were female (46.5%). Three distinct clinical phenotypes emerged: patients with small hematomas, elevated blood pressure, and Glasgow Coma Scale scores > 12 (n = 141, 26.6%); patients with hematoma expansion and elevated international normalized ratio (n = 204, 38.4%); and patients with median hematoma volumes of 24 (interquartile range 8.2-59.5) mL, who were more frequently Black or African American, and who were likely to have intraventricular hemorrhage (n = 186, 35.0%). There were associations between clinical phenotype and seizure (P = 0.024), length of stay (P = 0.001), discharge disposition (P < 0.001), and death or disability (modified Rankin Scale scores 4-6) at 3-months' follow-up (P < 0.001). We reproduced these three clinical phenotypes of ICH in an independent cohort (n = 385) for external validation.</p><p><strong>Conclusions: </strong>Machine learning identified three phenotypes of ICH that are clinically significant, associated with patient complications, and associated with functional outcomes. Cerebellar hematomas are an additional phenotype underrepresented in our data sources.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"39-47"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-08-07DOI: 10.1007/s12028-024-02062-7
Ori J Lieberman, Vanja C Douglas, Sara C LaHue
{"title":"Characteristics, Complications, and Outcomes of Critical Illness in Patients with Parkinson Disease.","authors":"Ori J Lieberman, Vanja C Douglas, Sara C LaHue","doi":"10.1007/s12028-024-02062-7","DOIUrl":"10.1007/s12028-024-02062-7","url":null,"abstract":"<p><strong>Background: </strong>Adults with Parkinson disease (PD) are hospitalized at higher rates than age-matched controls, and these hospitalizations are associated with significant morbidity. However, little is known about the consequences of critical illness requiring intensive care unit (ICU)-level care in patients with PD. The aim of this study was to define the characteristics and outcomes of adults with PD admitted to the ICU.</p><p><strong>Methods: </strong>We performed a retrospective nested case-control study using the Medical Information Mart for Intensive Care IV data set. Adults with PD were identified, and the index ICU admission for these subjects was matched 1:4 with index ICU admissions without a PD diagnosis based on age, sex, comorbidities, illness severity, ICU type, and need for mechanical ventilation. Primary outcomes were in-hospital mortality and discharge location. Secondary outcomes were length of stay and prespecified complications.</p><p><strong>Results: </strong>A total of 630 adults with PD were identified. Patients with PD were older and were more likely to be male, have more comorbidities, and have higher illness severity at presentation. A matched analysis revealed adults with PD did not have a significant difference in in-hospital mortality but were more likely to be discharged to a higher level of care. Adults with PD had longer hospital lengths of stay and increased odds of delirium, pressure ulcers, and ileus.</p><p><strong>Conclusions: </strong>During critical illness, patients with PD are at increased risk for longer hospital lengths of stay and complications and require a higher level of care at discharge than matched controls. These findings reveal targets for interventions to improve outcomes for patients with PD and may inform discussions about goals of care in this population.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"241-252"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141902478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Neurocritical CarePub Date : 2025-02-01Epub Date: 2024-08-08DOI: 10.1007/s12028-024-02084-1
Hyoung Youn Lee, Najmiddin Mamadjonov, Yong Hun Jung, Kyung Woon Jeung, Tae-Hoon Kim, Jin Woong Kim, Hyung Joong Kim, Jorge Antonio Gumucio, David D Salcido
{"title":"Relationships of Jugular Bulb Parameters with Cerebral Perfusion and Metabolism After Resuscitation from Cardiac Arrest: A Post-Hoc Analysis of Experimental Studies Using a Minipig Model.","authors":"Hyoung Youn Lee, Najmiddin Mamadjonov, Yong Hun Jung, Kyung Woon Jeung, Tae-Hoon Kim, Jin Woong Kim, Hyung Joong Kim, Jorge Antonio Gumucio, David D Salcido","doi":"10.1007/s12028-024-02084-1","DOIUrl":"10.1007/s12028-024-02084-1","url":null,"abstract":"<p><strong>Background: </strong>Cerebral blood flow (CBF) decreases in the first few hours or days following resuscitation from cardiac arrest, increasing the risk of secondary cerebral injury. Using data from experimental studies performed in minipigs, we investigated the relationships of parameters derived from arterial and jugular bulb blood gas analyses and lactate levels (jugular bulb parameters), which have been used as indicators of cerebral perfusion and metabolism, with CBF and the cerebral lactate to creatine ratio measured with dynamic susceptibility contrast magnetic resonance imaging and proton magnetic resonance spectroscopy, respectively.</p><p><strong>Methods: </strong>We retrospectively analyzed 36 sets of the following data obtained during the initial hours following resuscitation from cardiac arrest: percent of measured CBF relative to that at the prearrest baseline (%CBF), cerebral lactate to creatine ratio, and jugular bulb parameters, including jugular bulb oxygen saturation, jugular bulb lactate, arterial-jugular bulb oxygen content difference, cerebral extraction of oxygen, jugular bulb-arterial lactate content difference, lactate oxygen index, estimated respiratory quotient, and arterial-jugular bulb hydrogen ion content difference. Linear mixed-effects models were constructed to examine the effects of each jugular bulb parameter on the %CBF and cerebral lactate to creatine ratio.</p><p><strong>Results: </strong>The arterial-jugular bulb oxygen content difference (P = 0.047) and cerebral extraction of oxygen (P = 0.030) had a significant linear relationship with %CBF, but they explained only 12.0% (95% confidence interval [CI] 0.002-0.371) and 14.2% (95% CI 0.005-0.396) of the total %CBF variance, respectively. The arterial-jugular bulb hydrogen ion content difference had a significant linear relationship with cerebral lactate to creatine ratio (P = 0.037) but explained only 13.8% (95% CI 0.003-0.412) of the total variance in the cerebral lactate to creatine ratio. None of the other jugular bulb parameters were related to the %CBF or cerebral lactate to creatine ratio.</p><p><strong>Conclusions: </strong>In conclusion, none of the jugular bulb parameters appeared to provide sufficient information on cerebral perfusion and metabolism in this setting.</p>","PeriodicalId":19118,"journal":{"name":"Neurocritical Care","volume":" ","pages":"261-276"},"PeriodicalIF":3.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}